← 返回列表 › SCI 期刊 › 医学 › MUCOSAL IMMUNOL

Mucosal Immunology

MUCOSAL IMMUNOL

Print ISSN 1933-0219 Online ISSN 1935-3456
SCIE Q1 新锐1区 传统2区 Top期刊 混合OA 医学
影响因子 2026
5.5
↓ 2.1
5年均分
7.9
5-Year IF
H 指数
82
H-Index
年发文量
129
Articles / Year
出刊频率
Bimonthly
Pub. Frequency
创刊年份
2008
Founded Year
出版商
Elsevier Science Inc
Publisher
出版国家
USA
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
系统
暂无
约 2.8 个月
💰 版面费用
★★★★★
系统
暂无
官方APC $3,800 USD 约¥27,550
中科院分区
2026新锐分区 新体系
大类1区
医学Medicine
小类2区
免疫学Immunology
中科院2025年分区 传统体系
大类2区
医学Medicine
小类2区
免疫学Immunology
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q1
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
免疫学 Immunology SCIE Q1 45/183
75.4%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
免疫学 Immunology SCIE Q1 27/156 JCI 1.26
83.3%
Scopus 指标
CiteScore
15.7
综合引用得分
SJR
3.089 Q1
SCImago Journal Rank
SNIP
1.660
Source Normalized Impact
JCI
1.26
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

Mucosal Immunology is a leading peer-reviewed journal dedicated to advancing the understanding of the immune system as it operates at mucosal surfaces, including the gastrointestinal, respiratory, urogenital, and ocular tracts. Published by Springer Nature on behalf of the Society for Mucosal Immunology, the journal serves as a premier platform for research on the interface between host immunity and the diverse microbial, dietary, and environmental challenges encountered at these critical barriers. Its scope encompasses fundamental and translational studies on epithelial barrier function, innate and adaptive immune regulation, microbiota-host interactions, vaccine development, and the pathogenesis of mucosal inflammatory diseases such as inflammatory bowel disease, asthma, and celiac disease. The journal publishes a range of article types, including original research articles, comprehensive reviews, brief communications, and technical reports, alongside occasional editorials and meeting highlights. Its target audience includes immunologists, microbiologists, gastroenterologists, pulmonologists, and infectious disease researchers, as well as clinicians and biotechnologists focused on mucosal therapeutics. Notably, Mucosal Immunology offers both subscription and open access options, allowing authors to choose a publishing route that maximizes dissemination. With an Impact Factor of 5.500 (2026) and a consistent ranking in the Q1 quartile of the Immunology category, the journal is recognized as a top-tier, authoritative resource in its specialized field, reflecting high citation impact and rigorous peer review standards that attract cutting-edge work from leading laboratories worldwide.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.